AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11976562 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g young barley leaf extract (BL)
Number of subjects: 36
Study 11976562 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg vitamin C and 200 mg vitamin E (CE)
Number of subjects: 36
Study 11976562 — intervention group
Group type: EXPERIMENTAL
Intervention: BL plus CE (BL + CE)
Number of subjects: 36
Study 11276473 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 7
Study 11276473 — intervention group
Group type: COMPARATOR
Intervention: Optimum medical management (risk factor reduction and initiation of antiplatelet therapy)
Number of subjects: 7
Study 7831025 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 4
Study 7831025 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 4
Study 7831025 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis patients
Number of subjects: 4
Study 7831025 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 4
Study 29405226 — intervention group
Group type: EXPERIMENTAL
Intervention: Solanezumab (400 mg) every 4 weeks for 80 weeks
Number of subjects: 0
Study 29405226 — intervention group
Group type: EXPERIMENTAL
Intervention: Solanezumab (400 mg)
Number of subjects: 0
Study 29405226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28370397 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive education about dental implants delivered before the interview
Number of subjects: 66
Study 28370397 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive education about dental implants delivered after completing the questionnaire
Number of subjects: 66
Study 28370397 — intervention group
Group type: EXPERIMENTAL
Intervention: Information about implants from relatives or own dentist
Number of subjects: 66
Study 28370397 — intervention group
Group type: COMPARATOR
Intervention: Information about implants from the study dentist
Number of subjects: 66
Study 26599866 — intervention group
Group type: EXPERIMENTAL
Intervention: n-butanol exposure (3.7 ppm)
Number of subjects: 36
Study 22906391 — intervention group
Group type: EXPERIMENTAL
Intervention: Lip revision surgery
Number of subjects: 55
Study 21250860 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcaftadine 0.25% ophthalmic solution
Number of subjects: 58
Study 21250860 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 58
Study 19994698 — intervention group
Group type: EXPERIMENTAL
Intervention: Wooden needle treatment
Number of subjects: 120
Study 19994698 — intervention group
Group type: COMPARATOR
Intervention: Alprazolam (western medicine)
Number of subjects: 120
Study 16762126 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual healing (5 sessions)
Number of subjects: 88
Study 16762126 — intervention group
Group type: COMPARATOR
Intervention: Sham healing (placebo delivered by an actor)
Number of subjects: 88
Study 16762126 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal care only)
Number of subjects: 88
Study 14760591 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive harvested veins
Number of subjects: 200
Study 14760591 — intervention group
Group type: COMPARATOR
Intervention: Conventionally harvested grafts
Number of subjects: 200
Study 14760591 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive harvested grafts
Number of subjects: 200
Study 11318843 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus (GDM) group
Number of subjects: 401
Study 11318843 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-diabetic women)
Number of subjects: 401
Study 9228140 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail-delivered arthritis self-management program
Number of subjects: 809
Study 9228140 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention for first 6 months)
Number of subjects: 809
Study 7654434 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (3 mg/day)
Number of subjects: 309
Study 7654434 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (24 mg/day)
Number of subjects: 309
Study 7654434 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (3 mg/day) in patients receiving cisplatin
Number of subjects: 309
Study 7654434 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (24 mg/day) in patients receiving cisplatin
Number of subjects: 309
Study 7654434 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (3 mg/day) in patients receiving ifosfamide
Number of subjects: 309
Study 7654434 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (24 mg/day) in patients receiving ifosfamide
Number of subjects: 309
Study 7654434 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 309
Study 7654434 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 309
Study 3673682 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal neurolysis of the median nerve with a microsurgical technique
Number of subjects: 48
Study 3673682 — intervention group
Group type: COMPARATOR
Intervention: Simple division of the carpal ligament (flexor retinaculum)
Number of subjects: 48
Study 31039656 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin sterosomes
Number of subjects: 0
Study 31039656 — intervention group
Group type: COMPARATOR
Intervention: Metformin-free solution aerosol
Number of subjects: 0
Study 31039656 — intervention group
Group type: COMPARATOR
Intervention: Metformin sterosomes and metformin-free solution aerosol
Number of subjects: 0
Study 28578544 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop + Feedback
Number of subjects: 12
Study 28578544 — intervention group
Group type: COMPARATOR
Intervention: Workshop Only
Number of subjects: 12
Study 28578544 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Intervention Groups
Number of subjects: 12
Study 27465727 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme-Treated Asparagus Extract (ETAS) 150 mg/d for 28 days
Number of subjects: 0
Study 27465727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24108783 — intervention group
Group type: COMPARATOR
Intervention: 60,000 IU cholecalciferol
Number of subjects: 644
Study 24108783 — intervention group
Group type: COMPARATOR
Intervention: 30,000 IU cholecalciferol
Number of subjects: 644
Study 24108783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 644
Study 24108783 — intervention group
Group type: COMPARATOR
Intervention: 60,000 IU cholecalciferol in subjects aged ≥70 y
Number of subjects: 644
Study 24108783 — intervention group
Group type: COMPARATOR
Intervention: 60,000 IU cholecalciferol in subjects aged <70 y
Number of subjects: 644
Study 22510424 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixivaptan 100 mg once daily
Number of subjects: 170
Study 22510424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study 21037433 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (oxaliplatin- or irinotecan-based, at least 3 cycles)
Number of subjects: 1471
Study 21037433 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy
Number of subjects: 1471
Study 21037433 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy
Number of subjects: 1471
Study 21037433 — intervention group
Group type: COMPARATOR
Intervention: Control group (S)
Number of subjects: 1471
Study 21037433 — intervention group
Group type: COMPARATOR
Intervention: Control group (CS)
Number of subjects: 1471
Study 17960520 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrahospital supervised exercise training (3 weekly sessions of resistance and aerobic training for 8 weeks)
Number of subjects: 8
Study 17960520 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrahospital supervised exercise training
Number of subjects: 8
Study 17960520 — intervention group
Group type: COMPARATOR
Intervention: Control group (age and gender-matched healthy children)
Number of subjects: 8
Study 15663607 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 5 mg nasal spray
Number of subjects: 912
Study 15663607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 912
Study 14628180 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparing for Parenthood (PFP) intervention
Number of subjects: 0
Study 14628180 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative study of PFP intervention
Number of subjects: 0
Study 10584996 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin administered by the venous line
Number of subjects: 12
Study 10584996 — intervention group
Group type: COMPARATOR
Intervention: Nadroparin administered by the arterial line
Number of subjects: 12
Study 10584996 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin with part of the dose added to the priming solution
Number of subjects: 12
Study 10584996 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin administration (both routes)
Number of subjects: 12
Study 8712133 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline fibrinogen concentration > or = 300 mg/dl
Number of subjects: 1473
Study 8712133 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher fibrinogen concentrations in patients with spontaneous ischemia
Number of subjects: 1473
Study 8712133 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined unsatisfactory outcome of death, myocardial infarction, and spontaneous ischemia
Number of subjects: 1473
Study 1726199 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening group (alpha‐fetoprotein (AFP) screening every six months)
Number of subjects: 3958
Study 1726199 — intervention group
Group type: COMPARATOR
Intervention: Non-screening group
Number of subjects: 3958
Study 1726199 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening survey among males aged 30‐59 years with negative HBsAg (once a year)
Number of subjects: 3958
Study 1726199 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening group (alpha‐fetoprotein (AFP) screening)
Number of subjects: 3958
Study 1726199 — intervention group
Group type: COMPARATOR
Intervention: Out-patients (no screening)
Number of subjects: 3958
Study 6354929 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 12.5 mg t.i.d.
Number of subjects: 140
Study 6354929 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg t.i.d.
Number of subjects: 140
Study 6354929 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 37.5 mg b.i.d.
Number of subjects: 140
Study 6354929 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 50 mg t.i.d.
Number of subjects: 140
Study 6354929 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (H) alone
Number of subjects: 140
Study 6354929 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril plus Hydrochlorothiazide (C plus H) 12.5 mg
Number of subjects: 140
Study 6354929 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril plus Hydrochlorothiazide (C plus H) 25 mg
Number of subjects: 140
Study 6354929 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril plus Hydrochlorothiazide (C plus H) 37.5 mg
Number of subjects: 140
Study 6354929 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril plus Hydrochlorothiazide (C plus H) 50 mg
Number of subjects: 140
Study 30683103 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal gel and oral tablets for HIV prevention
Number of subjects: 171
Study 27734104 — intervention group
Group type: EXPERIMENTAL
Intervention: hyperinsulinaemic hypoglycaemia (HH; i.v. bolus of 0.1 U/kg insulin)
Number of subjects: 9
Study 27734104 — intervention group
Group type: EXPERIMENTAL
Intervention: hyperinsulinaemic euglycaemia (HE; i.v. bolus of 0.1 U/kg insulin and 20% glucose)
Number of subjects: 9
Study 27734104 — intervention group
Group type: COMPARATOR
Intervention: saline control
Number of subjects: 9
Study 27213436 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased total water intake (TWI) for HIGH group
Number of subjects: 120
Study 27213436 — intervention group
Group type: COMPARATOR
Intervention: Increased total water intake (TWI) for LOW group
Number of subjects: 120
Study 27213436 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIGH and LOW groups during the intervention
Number of subjects: 120
Study 24561057 — intervention group
Group type: EXPERIMENTAL
Intervention: rpMS
Number of subjects: 66
Study 24561057 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 66
Study 21852153 — intervention group
Group type: EXPERIMENTAL
Intervention: Atherothrombotic infarction
Number of subjects: 49
Study 21852153 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacunar stroke
Number of subjects: 49
Study 21852153 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioembolic stroke
Number of subjects: 49
Study 21852153 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 49
Study 20852275 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone prophylaxis
Number of subjects: 223
Study 20852275 — intervention group
Group type: EXPERIMENTAL
Intervention: Age over 8 years at onset
Number of subjects: 223
Study 20852275 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal pain
Number of subjects: 223
Study 20852275 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrence of HSP disease
Number of subjects: 223
Study 20852275 — intervention group
Group type: EXPERIMENTAL
Intervention: Two or three risk factors
Number of subjects: 223
Study 20852275 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine dipstick testing
Number of subjects: 223
Study 20852275 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up for nephritis
Number of subjects: 223
Study 17480153 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (25-26 degrees C)
Number of subjects: 15
Study 17480153 — intervention group
Group type: COMPARATOR
Intervention: Group II (32-33 degrees C)
Number of subjects: 15
Study 15227557 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential Multi Layered Perceptron (SMLP)
Number of subjects: 0
Study 15227557 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted screening (impaired glucose tolerance test) combined with SMLP
Number of subjects: 0
Study 11573751 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal setting
Number of subjects: 113
Study 11573751 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring
Number of subjects: 113
Study 11573751 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal setting and self-monitoring
Number of subjects: 113
Study 11573751 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal setting only
Number of subjects: 113
Study 11573751 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal setting and goal setting and self‐monitoring
Number of subjects: 113
Study 11573751 — intervention group
Group type: COMPARATOR
Intervention: Control group (no goal setting and no self‐monitoring)
Number of subjects: 113
Study 9757874 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-feeding practices
Number of subjects: 4118
Study 7949205 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (500 mg daily)
Number of subjects: 0
Study 7949205 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (lower dose without hydrocortisone)
Number of subjects: 0
Study 7949205 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (lower dose)
Number of subjects: 0
Study 7949205 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (initial high dose)
Number of subjects: 0
Study 7949205 — intervention group
Group type: COMPARATOR
Intervention: Testololactone
Number of subjects: 0
Study 3266277 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) treatment
Number of subjects: 11
Study 31843973 — intervention group
Group type: EXPERIMENTAL
Intervention: Married or partnered patients
Number of subjects: 367
Study 31843973 — intervention group
Group type: COMPARATOR
Intervention: Single patients
Number of subjects: 367
Study 31115060 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation intervention
Number of subjects: 107
Study 27260004 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT+nitrate (NIT)
Number of subjects: 27
Study 27260004 — intervention group
Group type: COMPARATOR
Intervention: SIT+placebo (PLA)
Number of subjects: 27
Study 26115578 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol at 80 μg/day
Number of subjects: 547
Study 26115578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 547
Study 23522911 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (aRT) 60Gy
Number of subjects: 385
Study 23522911 — intervention group
Group type: COMPARATOR
Intervention: Wait and see
Number of subjects: 385
Study 21999489 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg)
Number of subjects: 79
Study 19595295 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 145
Study 19595295 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 145
Study 19595295 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) and Prolonged Exposure (PE)
Number of subjects: 145
Study 17010995 — intervention group
Group type: EXPERIMENTAL
Intervention: CBZ plus FEWP (n=96)
Number of subjects: 188
Study 17010995 — intervention group
Group type: COMPARATOR
Intervention: CBZ plus placebo (n=92)
Number of subjects: 188
Study 17010995 — intervention group
Group type: EXPERIMENTAL
Intervention: FEWP monotherapy (36 g/day, n=86)
Number of subjects: 188
Study 17010995 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=63)
Number of subjects: 188
Study 15095554 — intervention group
Group type: EXPERIMENTAL
Intervention: TPA + TCD (2 hours of continuous monitoring with TCD)
Number of subjects: 126
Study 15095554 — intervention group
Group type: COMPARATOR
Intervention: TPA (standard 0.9 mg/kg TPA therapy)
Number of subjects: 126
Study 15095554 — intervention group
Group type: EXPERIMENTAL
Intervention: TPA + TCD
Number of subjects: 126
Study 15095554 — intervention group
Group type: COMPARATOR
Intervention: TPA
Number of subjects: 126
Study 11216320 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentence span task
Number of subjects: 0
Study 11216320 — intervention group
Group type: EXPERIMENTAL
Intervention: Arithmetic verification with recall of presented words
Number of subjects: 0
Study 11216320 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple resource model
Number of subjects: 0
Study 9825384 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity physical training on land
Number of subjects: 32
Study 9825384 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity physical training in water
Number of subjects: 32
Study 9825384 — intervention group
Group type: COMPARATOR
Intervention: Both training forms (land and water)
Number of subjects: 32
Study 7640924 — intervention group
Group type: EXPERIMENTAL
Intervention: iomeprol 350 mg I ml‐1
Number of subjects: 90
Study 7640924 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol 350 mg I ml‐1
Number of subjects: 90
Study 7640924 — intervention group
Group type: EXPERIMENTAL
Intervention: iopamidol 370 mg I ml‐1
Number of subjects: 90
Study 2520297 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily vitamin‐mineral supplement containing 2 or 3 mg of vitamin B6 for 9 days before surgery and multivitamin supplement containing 0.4, 0.8 or 2 mg of vitamin B6 for 3 months postoperatively
Number of subjects: 15
Study 2520297 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of supplemental vitamin B6 per day during the fourth month
Number of subjects: 15
Study 2520297 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative plasma PLP levels
Number of subjects: 15
Study 2520297 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate of weight loss
Number of subjects: 15
Study 2520297 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 15
Study 335968 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 143
Study 335968 — intervention group
Group type: COMPARATOR
Intervention: Cephalothin
Number of subjects: 143
Study 31246878 — intervention group
Group type: EXPERIMENTAL
Intervention: BWL therapy (30-minute exposure to waking white light enriched with blue for 4 weeks)
Number of subjects: 0
Study 31246878 — intervention group
Group type: COMPARATOR
Intervention: N-BWL (no light therapy)
Number of subjects: 0
Study 31382201 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher CBD and lower price
Number of subjects: 2400
Study 31382201 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher THC
Number of subjects: 2400
Study 31382201 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic warning on drugged driving
Number of subjects: 2400
Study 31382201 — intervention group
Group type: EXPERIMENTAL
Intervention: Text warning message
Number of subjects: 2400
Study 31382201 — intervention group
Group type: EXPERIMENTAL
Intervention: FDA disapproval disclaimer
Number of subjects: 2400
Study 31382201 — intervention group
Group type: EXPERIMENTAL
Intervention: Price
Number of subjects: 2400
Study 31382201 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD
Number of subjects: 2400
Study 28402191 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval running on grass surface
Number of subjects: 10
Study 28402191 — intervention group
Group type: COMPARATOR
Intervention: Interval running on sand surface
Number of subjects: 10
Study 25432966 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics treatment
Number of subjects: 260
Study 25432966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study 23958818 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydromorphone
Number of subjects: 50
Study 22076901 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture (10 sessions at the rate of three sessions per week)
Number of subjects: 31
Study 22076901 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 31
Study 19302739 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic assisted vaginal hysterectomy (LAVH)
Number of subjects: 101
Study 19302739 — intervention group
Group type: EXPERIMENTAL
Intervention: Total vaginal hysterectomy (TVH)
Number of subjects: 101
Study 19302739 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (TAH)
Number of subjects: 101